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We functionally characterized human skin mast cell carbox-
ypeptidase A (MC-CPA), and explored its evolutionary rela-
tionship to other carboxypeptidases to understand further the 
structural basis for the substrate preferences of this enzyme. 
Purified human skin MC-CPA displayed more activity than 
did bovine pancreatic carboxypeptidase A (CPA) against car-
boxyl-terminal leucine residues, about equal activity with 
phenylalanine and tyrosine residues, and no activity with 
tryptophan or alanine. To correlate kinetic data with struc-
ture, we isolated and sequenced a cD N A encoding MC-CP A 
from human skin, and directly sequenced 30% of the purified 
protein. These sequences agreed with that of human lung 
MC-CPA, and further support the evidence for a single MC-
CPA gene in humans. Four amino acid replacements, result-
ing in a net positive change in non-hydrogen atoms in the S l' 
subsite of MC-CPA, were associated with less alteration 
H uman mast cel l carboxypeptidase (MC-CPA) [1,2] is one of four neutral proteases identified in human mast cells, along with tryptase [3] , chymase [4-6], and a cathepsin G - like protease [7]. These mast cell enzymes are homologous with pancreatic proteases 
[2,8- 10]. MC-CPA has substrate specificity similar to pancreatic 
carboxypeptidases A in that it recognizes hydrophobic carboxyl-
terminal residues, and not the basic residues, Arg or Lys, recognized 
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Abbreviations: 
AI: angiotensin I 
BCIP: 4-ch loro-1-naphtol, 5-bromo-4-chloro-3-indolyl phosphate-
toluidine sa lt 
Chz-G ly-G ly-Ala: carbobenzoxy-glycyl-L glycyl-L-alanine 
Cbz-Gly-Gly-Leu: carbobenzoxy-glycyl-L glycyl-L-leucine 
Cbz-Gly-G ly-Phe: carbobenzoxy-glycyl-L glycyl-L-phenylalanine 
in substrate specificity, relative to bovine CPA, than might be 
expected from studies using rat CPA 1 and CP A2. W e noted 
two consensus N-linked glycosylation sites in human MC-
CPA that are not found in rat and mouse MC-CPA, or in 
bovine CPA; that at least one of these sites is glycosylated in 
vivo was verified by N-glycosidase F treatment, lentil lectin 
binding, and Concanavalin A - Sepharose chromatography. 
~volutionary trees constructed from the known carboxypep_ 
tIdase sequences suggested that MC-CP A most likely 
evo lved from a carb?xypeptidase B~like enzyme, indepen-
dent of the pancreatic CPA. Thus, III the carboxypeptidase 
gene family , MC-CPA displays a unique genealogy and sev-
eral amino acid replacements in its S l' binding pocket that 
result in substrate specificity quite similar to bovine CPA. 
] [,west Dermatol99:138-145, 1992 
by carboxypeptidase B. Yet, MC-CPA has not been as extensively 
characterized with regard to substrate preferences as have pancreatic 
carboxype12tidases [2,11 ]. In addition, the sequences of human [9] , 
mouse [12J, and rat [13] MC-CPA have not been analyzed with 
regard to Sl' subsite* replacements that appear to correlate with 
substrate preferences of CPA enzymes [11], although the M C-CPA 
sequences have revealed an amino acid replacement in the substrate 
binding site that appears critical for the hydrolysis of hydrophobic 
Cbz-Gly-Gly-Trp: carbobenzoxy-glycyl-L glycyl-L-tryptophan 
Cbz-Gly-Gly-Tyr: carbobenzoxy-glycyl -L glycyl-L-tyrosine 
C PA: carboxypeptidase A 
CPB: carboxypeptidase B 
LEP: lysylendopeptidase 
MC-CPA: mast cell carboxypeptidase A 
MCT : mast cells staining positive for tryptase and negative for chy-
mase, carboxypeptidase, and a cathepsin G - like enzyme 
MCTC : mast ce lls staining positive for tryptase, chymase, carboxy-
peptidase, and a cathepsin G - like enzyme 
NBT: p-nitro-blue-tetrazolium chloride 
PCR: polymerase chain reaction 
PEG: polyethylene glycol 
SBTI: soybean trypsin inhibitor 
SDS-PAGE: sod ium dodecyl sulfate- polyacry l amide gel electropho-
reSiS 
TFA: trifluoroacetic acid 
• The S1' subsite of the enzyme refers to the binding pocket for the 
carboxyl-terminal amino acid of the substrate in accordance with the no-
menclature of Schechter and Berger [1 4]. 
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residues [9,12,13,15]. Finally, human mast cell tryptase and chy-
mase are glycosylated in vivo [16,17], but MC-CPA has not been 
studied in this regard. Glycosylation appears to be characteristic for 
human and dog mast cell neutral proteases, but not for the corre-
sponding rat enzymes [18] . In this work we have compared the 
substrate preferences of MC-CPA purified from skin to that of 
bovine pancreatic CPA, and we have also demonstrated that MC-
CPA is glycosylated in vivo. In order to investigate the relationship 
of the kinetic and glycosylation data with the sequence of MC-
CPA, we iso lated and sequenced a cDNA encoding MC-CPA from 
skin and directly sequenced several protease-generated fragments of 
MC-CPA, constituting approximately 30% of the purified protein. 
The sequence of human MC-CPA cDNA from skin was identical to 
the enzyme from human lung [12] . This is consistent with evidence 
suggesting that only one MC-CPA gene is expressed in humans 
[12] . The amino acid sequences of mast cell carboxypeptidases are 
more similar in overall sequence to the carboxypeptidase B (CPB) 
enzymes rather than to the CPA [2,9,12], suggesting a closer evolu-
tionary relationship. To establish the genealogy of the carboxypep-
tidase fami ly, we built parsimony trees from the known sequences; 
these trees suggest that the gene duplication that gave rise to the 
mast ce ll carboxypeptidases occurred along the CPB lineage. 
MATERIALS AND METHODS 
Materials The following oligonucleotides were synthesized by 
the Biomolecular Resource Center at UCSF: #7506 5'-GAG ATT 
TCC AAG CTT GGG GAA CGA TTT TTT CTC CAC ATG 
CGG TTC TTT GTC CAT GAC C -3'; #7505 5-' GAG CGG 
CCGCCTCGAGTCGACCCCAGGCAGGCACAGCTA 
CGC AAA ATA C -3' . Oligonucleotide #BS09 5'-TAC AAC 
AAC TGG GAG AAG ATI GTI GCI TGG ACI GAG AAG ATG 
ATG GA-3' was synthesized by the Hormone Research Institute at 
U CSF. 
Acetonitrile (Pierce), Guanidine-HCl (Aldrich) , Gigapack Gold 
(Stratagene), Leucine aminopeptidase (Worthington) ; Tween 20, 
4-chloro-l-naphtol, 5-bromo-4-chloro-3-indolyl phosphate-to I ui-
dine salt (BCIP) ; p-nitro-blue-tetrazolium chloride (NBT) 
(Biorad); biotin-conjugated lentil lectin, avidin-conjugated horse 
radish peroxidase (EY Laboratories); Centricon 10 microconcentra-
tors (Amicon) ; MgCl2 (Mallinckrodt) ; TFA (Pierce); Chromozyme 
PL (Tosyl-Gly-Pro-Lys-p-nitranilid-acetate) (Boehringer Mann-
heim); QUIK-SEP columns (ISOLAB); Angiotensin I (Star Bio-
chemicals Inc.); SBTI (Calbiochem); Nitroplus 2000 membranes 
(Fisher); Concanavalin A Sepharose (Pharmacia); Nonidet p-40, 
.a -methyl-D-mannopyranoside, gelatin (Sigma); phenol, Blugene, 
protease K, Kpn I, Hind Ill, T 4 polynucleotide kinase (BRL); Se-
quenase (US Biochemical); Erase-a-base (Promega); carbobenzoxy-
glycyl-L-glycyl-L-alanine (Cbz-Gly-Gly-Ala) , Cbz-Gly-Gly-Phe, 
Cbz-Gly-Gly-Leu, Cbz-Gly-Gly-Tyr, and Cbz-Gly-Gly-Trp (Ba-
chem); N-glycosidase F (Genzyme) were obtained as noted. 
METHODS 
Purification ofMC-CPA and Bovine CPA MC-CPA was pu-
rified to a single band on SDS-PAGE using a single-step affiniry-
purification procedure as previously described [2] . Bovine pancre-
atic CPA (Sigma) was repurified by HPLC on a MonoQ HR5/5 
anion exchange column (Pharmacia). Protein was applied to this 
column in 20 mM Tris, pH 8.0, 20 mM N aCl, and eluted with a 
linear gradient up to 200 mM N aCI. Bovine pancreatic CPA was 
stored at 4 ° C. Protein concentrations were determined spectropho-
tometrically using the value of 6.42 X 104 M- l cm- 1 as the extinc-
tion coefficient at 278 nm for bovine CPA [19], and by Coomassie 
blue binding (Biorad) for MC-CPA using bovine serum albumin as 
a standard. The determination of M C-CPA concentration by the 
Biorad assay correlated well with that determined by titration of 
MC-CPA against potato carboxypeptidase inhibitor [20], when 
compared using another preparation of MC-CPA. The concentra-
tion of catalytic centers of MC-CPA was determined using the 
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protein concentration of MC-CP A and the specific activity of the 
preparation we used (1 2.0 U/ f1 g protein) compared to our prepara-
tion with the highest specific activity (36.4 U/f1g protein) [2]. 
Enzyme Assays MC-CPA and bovine CPA activities eluting 
from Concanavalin A-Sepharose were measured by the hydrolysis 
of the carboxy terminal His9-Leu 10 bond of angiotensin I as de-
scribed previously [1]. MC-CPA and bovine CPA hydrolysis of 
synthetic tripeptide substrates (Cbz-Gly-Gly-X, where X was the 
substituted carboxy terminal amino acid Leu, Phe, Tyr) were mea-
sured twice at several enzyme concentrations and four to five sub-
strate concentrations in a 500-f1l volume of 0.01 M Tris HCl (pH 
8.0),0.15 M N aCl, for 7 min at room temperature. Cbz-Gly-Gly-
Phe was used at 10 to 80 f1M, Cbz-Gly-Gly-Leu at 50 to 800 f1M, 
and Cbz-Gly-Gly-Tyr at 25 to 200 f1M . Cbz-Gly-Gly-Trp and 
Cbz-Gly-Gly-Ala were used at 100 f1M and at 5 f1M and 50 f1M, 
respectively. The reaction was stopped with an equal volume of 
HPLC buffer (0 .017 M H3HP04 , 0.1 M N aC10 4 in 35% C H3CN) , 
and assayed on a Beckman model 144 HPLC system by using a 
4.6 X 250 mm Altex ultrasphere 5 f1m ODS C18 column employ-
ing an isocratic perchlorate ion-pai r reverse-phase system using 
HPLC buffer at a flow rate of 1.0 mljmin [21] . The product, Cbz-
Gly-Gly, was monitored by absorbance at 200 nm, identified by 
retention time, and quantified by integration of peak area by using a 
Hewlett Packard HP 3390E integrating recorder. With the use of 
this system, Cbz-Gly-Gly eluted at approximately 4.15 min . The 
kinetic constants K", and kcar were obtained by direct fit of 4 -10 data 
points for each enzyme concentration using a non-linear least-
square regression analysis [22]. 
Binding of MC Proteases to Concanavalin A-Sepha-
rose Bovine pancreatic CPA and purified MC-CPA were dia-
lyzed against wash buffer (6 mM KH2P04 , 30 mM N 2HP04 , pH 
7.6,0.1 mM CaCI2 ,0.5 M NaCl, 0.1 mMMnCI2 ' 4H20,and 0.1% 
PEG). A I-ml aliquot of each enzyme was independently mixed 
with 1 ml of Concanavalin A - Sepharose (Pharmacia) that was pre-
equilibrated in wash buffer. The slurry was mixed for 40 min at 
25 ° C using a multi-purpose rotator (Scientific Industries) and 
poured into a Quik-sep column (Isolabs). The effluent was collected 
and the column was washed with 15 vol of wash buffer, and then 
was eluted with 15 ml of 1 M a-methyl -D-mannopyranoside 
(Sigma) in wash buffer. Aliquots weJ;,e assayed for carboxypeptidase 
activity using AI as described above. 
N-Glycosidase F Treatment of MC-CPA Purified MC-CPA 
(36 f1 g) was concentrated and desalted using a Centricon 10 micro-
concentrator (Amicon) , dried under vaccum, and redissolved in 30 
f1l of 0.5 % SDS, and treated with N-glycosidase F as described [1 8]. 
Aliquots of MC-CPA treated identically but with or without N-
glycosidase F were analyzed on a 12.5% polyacrylamide-SDS gel. A 
2-f1l sample of each aliquot was also applied to nitrocel lulose , incu-
bated with biotin-conjugated lentil lectin overnight, and visualized 
as described [18]. 
Protein Sequencing Peptide fragments of MC-CP A were made 
using lysyl-endopeptidase and leucine aminopeptidase digestion, 
lysylendopeptidase digestion and separation of peptides [23]' 70 Jig 
of purified MC-CPA was incubated in 3.55 M guanidine-HC1, 0.05 
M Tris-HC1, pH 8.9, and 4.4 mU of lysylendopeptidase (LEP) for 
16 h at 30 °C, after which a second aliquot of lysylendopeptidase 
was added and the incubation continued for 18 h. A control was 
performed containing all components except MC-CPA. Three 
hundred fifty microliters of the sample was then subjected to re-
verse-phase HPLC using a Rainin Rabbit binary pumping system 
and Hewlett Packard 1040A diode array detector, equipped with a 
79994a ChemStation. The pep tides were separated by HPLC on a 
Brownlee C-8, RP300, 2.1 X 300 mm column, using a gradient 
program that consisted of injection and 5-min wash with solvent A 
(0.1 % T FA in water), followed by a linear ramp to 100% solvent B 
(70% CH3CN/ 30% water/ O.l % TFA) at 200 f1l/min in 45 min. 
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Fractions were dried to completeness in a speed vacuum concentra-
tor, and those containing the most protein were subjected to se-
quencing as described below. 
Leucine aminopeptidase digestion: an aliquot of one HPLC frac-
tion from the LEP digestion, whose amino acid sequence began at 
residue 224, was dissolved in a solution that consisted of 200,u1 of 
0.01 M Tris/HCI, pH 8.8, 4 mM MgCI2 , and 0.6 U of leucine 
aminopeptidase, which had been previously pre-incubated for 2 h at 
37"C. A sample containing all components except peptide substrate 
served as a control. The reactions were incubated for 14 h at 37" C, 
then subjected to HPLC, exactly as described above. 
Protein sequencing was performed at the Biomolecular Resource 
Center at the University of California San Francisco. Fractions were 
sequenced by automated Edman degradation on a model 470 A 
gas-phase protein sequencer (Applied Biosystems, Inc., Foster City, 
CAl equipped with an on-line 120 PTH Analyzer. 
Cloning and Screening 
Lung Mast Cell Library: A cDNA library from dispersed lung cells 
containing 40% mast cells constructed in A ZAP (Stratagene) was 
used [24] . A 47-bp degenerate oligonucleotide (oligonucleotide 
BS09) was synthesized based on residues 12 to 27 of human MC-
CPA [2]. The oligonucleotide was end labeled with 32p y-ATP and 
T4 polynucleotide kinase and used to screen approximately 106 
clones of the lung mast cell library [25]. 
Dermal Cell Library A eDNA library was constructed as de-
scribed from dispersed human dermal cells, containing 4 X 106 mast 
cell s of 1 % purity, from a single donor [10]. The library was ampli-
fied prior to screening using a protocol provided by the manufac-
turer (Stratagene). 8 X 105 independent recombinants were ob-
tained prior to amplification. Approximately 2 X 106 plaques were 
screened. Briefly, plaque lifts were made using Nitroplus 2000 
membranes. After denaturing and neutralization, filters were 
treated with 0.5 mg/ml protease K in 2 X SSC, 0.1 % SDS, at 37"C 
for 1 h to decrease background prior to washing and prehybridiza-
tion . The cDNA (hL 4-3) obtained from the human lung mast cell 
library was biotinylated using the supplier's protocol (Blugene, 
BRL). Hybridization was carried out with 0.1 ,ug/ml of probe at 
42 °C overnight in 45% formamide, 5 X SSC, 1 X Denhardt's so-
lution, 20 mM NaP04 (pH 6.5), 0.2 ,ug/ml herring sperm DNA. 
The filters were washed in 0.16 X SSC, 0.1 % SDS, for 15 min at 
50 °C, then incubated with a streptavidin-alkaline phosphatase con-
jugate. The clones were visualized using NBT and BCIP, using the 
supplier's protocol. 
cDNA Sequencing Clone hL 4-3 isolated from the human lung 
mast cell library was sequenced directly in bluescript SK using dou-
ble-stranded di-deoxynucleotide chain termination sequencing [26] 
[Sequenase (USB)]. 
N ested deletions were made of the clone hS-I in bluescript SK 
from the human dermal cell library using a kit (Erase-a-Base) ac-
cording to the supplier's protocol. Briefly, the clone was digested 
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with Kpn I and Hind III, and incubated with Exonuclease III at 
25 ° C. Aliquots removed at I -min intervals, and subjected to agar.ose 
gel electrophoresis, demonstrated deletions of increasing ~IZ~ . 
These deleted clones were ligated and used to transform Eschencl/la 
coli HBI01. For sequencing in the reverse direction, the clone was 
first digested using Xba I, then treated with alpha phosphor-
othioate, and finally digested with Bam HI. Exonuclease III diges-
tion at 30°C was followed by ligation, transformation, and se-
quencing as described above. 
Polymerase Chain Reaction Total RNA was extracted from 
several preparations of dispersed skin mast cells of 11-13% pUrIt)' 
in a single step using acid guanidinium and phenol-chloroform [271j 
Polyadenylated RNA was prepared using a kit (Pharmacia). Tota 
RNA (5 ,ug) or mRNA (1 ,ug) was reverse transcribed using ~V 
reverse transcriptase (BRL) and 5 pmol of primer 7506 encodl?g 
nucleotide 341 to 388 ofMC-CPA plus EcoR I and Hind III reStriC-
tion sites. The cDNA was diluted 1/50 in water. One and t.en 
microliters were amplified using 30 cycles of PCR in a Perkln-
Elmer Cetus DNA thermal cycler using primer 7506 and an up-
stream primer (7505). Primer 7505 included MC-CPA sequenc~ 
extending from BP 3 to BP 30 coupled to 5' -Not I, Xho I, and Sal 
sites. PCR was initiated with 2.5 U T AQ polymerase, and run at an 
annealing temperature of 60°C and extension at 72 °C. Both reaC-
tions showed single bands at - 450 BP. The products were ethanol 
precipitated, digested by Hind III and xho I, and cloned into plah mid bluescript KS. The clones were directly sequenced in bot 
directions from nucleotides 31 to 327. 
Evolutionary Analysis Amino acid parsimony trees were built 
from the carboxypeptidase sequences shown in Fig 4 by the com-
puter program PROTOP ARS in the phylogenetic-analysis package 
PAUP [28]. All possible unrooted trees (135,135) for nine sequencdS 
(leaving out either mouse MC-CPA or rat MC-CPA) were teste· 
Those residues at the N- and C-termini that are missing for some 
sequences due to differing lengths of the proteins were coded as 
" unknown" for the purposes of tree building. The number of"wllJ-
ning sites" were counted for the four shortest trees (from the "tre)e 
steps" column under "character diagnostics in the PAUP output , 
and a statistical test applied as described previously [11]. The treeS 
were rooted by "outgroup" using the Streptomyces griseus sequences. 
RESULTS 
M C-CP A and Bovine Pancreatic CPA Have Similar but Dis' 
tinct Substrate Specificities The activities of purified hU!11~n 
MC-CPA and bovine pancreatic CPA were determined on a serIes 
of synthetic tripeptide substrates, Cbz-Gly-Gly-X, where X wad 
Ala, Leu, Phe, Tyr, or Trp. The calculated kinetic constants Km an 
k
c
• t are shown in T able I. MC-CP A and bovine CPA have silUllar, 
but not identical, substrate preferences. Specifically, MC-CPA de~: 
onstrated no measurable activity toward the substrate with the slUal 
es t C-terminal amino acid, Ala, as well as none against the subs~ratf 
with Trp, the largest. Bovine CPA demonstrated no hydrolYSIS 0 
Table I. .Kinetic Constants for Substrate Hydrolysis by MC-CPA and Bovine CPA" ------------------------~----------------------~----------------------------------------------
MC-CPA Bovine CPA 
---
Lt/V (10- 5) ------------- (10- 5) 
_ n . .", k"./K"'_INCI 
Substrate kc" (second- I) Km (Ilm) second- 1M-I kc" (second- I) K.", (Ilm) secon~
Cbz-Gly-Gly-Ala NOb NO NO NO NO ND 
Cbz-Gly-Gly-Leu 21 ± 0.7 160 ± 14.5 1.3 52 ± 7.2 930 ± 260 0.56 
Cbz-Gly-G ly-Phe 23.5 ± 1.6 26.5 ± 2.3 8.9 72 ± 5.9 98 ± 19 7.3 
Cbz-G ly-Gly-Tyr 19 ± 0.4 27 ± 0.1 7.0 56 ± 2.0 102 ± 2.3 5.5 
Cbz-G ly-G ly-Trp NO NO NO ~ 
• Purified MC-CPA and bovine CPA were incubated with four to five concentrations of each substrate, and the product Cbz-Gly-Gly was measured by HPLC as described 10 
experimental procedures. Values are given as mean ± SE. 
! NO, no hydrolysis was detected. 
, Hydrolysis was measurable but too low for determination of kinetic constants. 
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~1ure 1. Binding of purified human skin MC-CPA and bovine pancreatic 
Sto Concanavalin A-Sepharose. The percent of starting activity recov-
ere In effluent, wash, and elute fractions is shown. 
C~z-GlY-GlY_Ala, but did hydrolyze Cbz-Gly-Gly-Trp. kat and K.n 
~b Ues Were measurable for three substrates, Cbz-Gly-Gly-Len, 
Cpz-GlY-Gly-Phe, and Cbz-Gly-Gly-Tyr. The kc>t values ofMC-
I A Were similar for all three substrates, and were two- to threefold 
~;er than those of bovine CPA. However, the Km values of MC-
GI A Were four- to sixfold lower for Cbz-Gly-Gly-Phe, Cbz-Gly-t Tyr, and Cbz-Gly-Gly-Leu compared to CPA. The kcaJK.n 
vh ues of MC-CPA and CPA were similar for these substrates. AI-\ ough Cbz-Gly-Gly-Leu was the most poorly hydrolyzed of these ~ree substrates by both enzymes, the higher catalytic efficiency of 
dC-CPA compared to bovine CPA with this substrate was largely 
Ue to lower Km values, perhaps reflecting tighter binding. 
~~'CPA Is a Glycoprotein To determine whether MC-CPA 
sr. ycosylated, we examined the binding ofMC-CPA to Concana-~.~ In A-Sepharose, an immobilized lectin that binds polysaccha-
/ es. We also hydrolyzed asparagine {N)-linked polysaccharides 
torn MC-CPA using N-glycosidase F, and investigated the subse-~.~nt change in mobility of MC-CPA on SOS-PAGE and in its 
a t tty to bind lentil lectin. 
A B c o 
94K 
67K 
43K 
30K 
20.1K 
b 
HUMAN MAST CELL CARBOXYPEPTIDASE FROM SKIN 141 
Purified MC-CPA and bovine CPA were independently applied 
to Con A-Sepharose. Whereas 76% of purified MC-CPA was re-
covered in the eluate from Con A - Sepharose, only 3% of CPA was 
recovered in the eluate, the rest of the activity appearing in the 
effluent and washes (Fig 1). This suggests that human MC-CP A, 
but not bovine CPA, is glycosylated. When purified MC-CPA was 
treated with N-glycosidase F to remove N-linked polysaccharides, 
its apparent Mr on SOS-PAGE decreased by 3500 from 39,800 to 
36,300 (n = 2) (Fig 2a). MC-CPA was then immobilized on nitro-
cellulose and incubated with lentil lectin. The lectin binding of 
MC-CPA treated with N-glycosidase F was markedly reduced 
compared to control enzyme (Fig 2b) . T aken together, these find-
ings suggest that human MC-CPA is glycosylated in vivo. 
The Sequence of Skin MC-CPA Reveals It Is Identical to 
Lung MC-CPA Filter hybridization screening of the lung mast 
call cONA library using oligonucleotide BS09 yielded one clone 
with 500-bp insert (hL 4-3). Partial sequencing of this clone and 
comparison of its deduced amino acid sequence to those of CPA and 
CPB in the Dayhoff protein sequence data base, using the computer 
algorithm dfastp, revealed that hL 4-3 encoded part of the signal 
peptide, the activation peptide, and the N-terminal portion of a 
carboxypeptidase-like enzyme to amino acid 48 (numbering in Fig 
3). The deduced amino acid sequence of the clone was identical to 
that of the N-terminal amino acid sequence of MC-CPA obtained 
previously (2). This cDNA was used to screen the dermal cell li-
brary. Screening yielded one cDNA clone of approximately 1.6-Kb 
(hS-I). This clone was sequenced fully in both directions . Compari-
son of the nucleotide sequence of hS-I with that of other carboxy-
peptidases showed the sequence extended from part of the signal 
peptide through the 3' untranslated region (not shown). Compari-
son of the deduced protein sequence of hS-I with sequences for the 
other carboxypeptidases revealed a likely deletion of nucleotides 
coding for amino acids 78 through 91 (i.e., bp 232-273 in Fig 3). 
Therefore, a PCR fragment extending from bp 31 to 327 was ob-
tained using messenger and total RNA; the sequence revealed the 
additional nucleotides present in the mRNA population, suggesting 
the deletion was a cloning artifact. Figure 3 shows the composite 
cDNA sequence encoding mature MC-CPA from human skin mast 
cells and its deduced protein sequence. The deduced amino acid 
sequence was compared to amino acid sequence obtained from pro-
tein sequencing of approximately 30% of the enzyme. Where pro-
tein sequence data was available, the amino acids are underlined in 
A B 
Bigu 1v!C-~ep 2. aJ Denaturing gel electrophoresis of glycosidase-treated MC-CPA. Lane B: MC-CPA treated overnight without glycosidase treatment. Lane C: 
36,300 t treated with glycosidase; they are flanked by molecular weight markers (lan es A and D). The calculated Mr of the band in [atle B is 39,800 versus 
(tnagn'/i Or Ialle C. b) Nitrocellulose dot blot of MC-CPA incubated with lentil lectin. A) No glycanase treatment; B) with N-glycosidase F treatment 
1 catlonX15). 
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1 : ATe CCA GGC AGG CAe AGe 'lAC GC.A AAA TAC AAT AAT TGG GAA AAG 
I G R H S YAK Y NNW E K 
46 : ATT GTG GeT TGG ACT GM AAG ATG ATG GAT AAG TAT ceT GAA ATG 
V A WorK M M D K Y P E M 
91 : GTe TCT CGT ATT AAA ATT eGA 'lCT ACT GTT GAA GAT AAT CCA eTA 
v S R K I G S V E D N P L 
136: TAT GTT CTG AAG ATT GGG GAA AAG A.A.T GAA AGA AGA AAG GCT ATT 
YVLK G KNERRICAI 
181: TTT ATG GAT TGT GGC ATT CAC GCA CGA GAA TGG GTC TCC CCA GCA 
FHDCG oAR WVS A 
226: TTe TGC CAG TGG TTT GTe TAT CAG GCA Ace AAA ACT TAT GGG AGA 
F C Q W F V Y 0 A K T Y G R 
271: Me AAA ATT ATG Ace AAA eTC TTG GAC eGA ATG A.A.T TTT 'lAC ATT 
N It I H T K LOR M N FYI 
316 : CTT ceT GTG TTe A.A.T GTT GAT GGA TAT ATT TGG TCA TGG ACA AAG 
L VFNVDGY wsw K 
361: Me CGC ATG TGG AGA AAAI AAT CGT Teel AAG Me CAA Me Tee AAA 
N R M W R K. N R S. K N Q N S K 
406 T~ AiC ~ A;T G~C C~C~~T T;T[~T ~T T~[T~ ~C 
451 : Tee ATT ceT Me Ace A.A.T GAC CCA TGT GCA GAT M e TAT eGG GGC 
51 NTND CADNYRG 
496 : TCT GCA CCA GAG Tee GAG AAA GAG ACG AAA GeT GTe ACT AAT TTe 
SAP ESE K T K A V T N F 
541: ATT AGA AGe CAe CTG A.A.T GAA ATe A.AG GTT TAC ACT ACC TTC CAT 
RS LNE KVYTTF 
586 : TCC TAC TCC CAG ATG CTA TTG TTT CCC TAT GGA TAT ACA TCA AAA 
SYSQHLL YGYTSK 
631: CTG CCA CCT Me CAT GAG GAC TTG GeC AAA GTT GCA AAG ATT GGC 
LPN EDLAKVAKIG 
676: ACT GAT GTT eTA TCA ACT CGA TAT GAA ACC CGA TAC ATe TAT GGC 
DVL TRY RYIYG 
721; 
766: TGG GeT TAT GAC C'PG GGC ATC A.AA CAC ACA TTT~ TTT GAG CTC 
WAY D L G I K H T F ~ F E L 
8 11 : CGA GAT AM GGC AM TTT GGT TTT CTC CTT CCA GAA TCC CGG AT A 
R 0 It G K G F L L R 
856: AAG CCA ACG TGC AGA GAG ACC ATG CTA GCT GTC AM TTT ATT GCC 
K TCRE HLAVKFIA 
901 : AAG TAT ATC CTC AAG CAT ACT TCC TAA 
" y K H S stop 
15 
30 
45 
60 
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90 
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Figure 3. Composite cDN A sequence and deduced protein sequence of the 
catalytic portion of MC-CPA. The amino acid sequences determined by 
direct protein sequencing are lIllderlilled. Consensus N-linked glycosylation 
sites are boxed. Amino acids corresponding to residues in the 51' subsite of 
bovine pancreatic CPA are circled. 
Fig 3. At all positions the deduced and directly obtained amino acid 
sequences agreed. The sequence of the skin MC-CPA cDNA is 
identical to that reported for human lung MC-CPA cDNA [9]. 
Analysis of DNA and Protein Sequence Comparison of the 
sequence of bovine pancreatic CPA with that ofMC-CPA indicates 
four replacements of amino acid residues that have been localized by 
X-ray crystallography to the Sl' binding site of pancreatic carboxy-
peptidase A [11,15,29]. These replacements in MC-CPA occur at 
positions lie 249, Ser 252, and Ala 267 (Fig 3), which correspond to 
positions Ala 250, Gly 253, Thr 268, respectively, of bovine CPA 
(Fig 4) , in addition to the previously discussed reflacement of Leu 
254 in MC-CPA for lie 255 of bovine CPA [9,12. Thus MC-CPA 
has one isomeric, one smaller, and two larger amino acids in the SI' 
site compared to bovine CPA. 
The presence of two consensus sequences for N-linked glycosy-
!ation sites [30-32] at Asn 127-Arg 128-Ser 129, and Asn 146-
Ala 147 -Ser 148 (Fig 3) is consistent with the observation that 
MC-CPA is glycosylated in vivo. Using the computer program 
INSIGHT II (Biosym Technologies, Inc.), the tertiary structure of 
bovine CPA was displayed, and we determined that Thr 148 (the 
amino acid corresponding to MC-CPA Asn 146) is located on the 
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Figure 4. Sequences of carboxypeptidases used to construct evolutionary 
trees, aligned with regard to the primary sequence for bovine CPA. Dashes 
indicate gaps in the sequences required for alignment, and thus represelJ1 
amino acid deletions. Asterisks highlight amino acid residues localized to [he 
51' subsite of bovine CPA [11]. Question marks indicate differences in sed 
quence due to length variation at the N- and C- termini of the enzymes. an. 
code these positions as "uncertain" for the purposes of parsimony analysl~ 
[28]. Sequences for bovine CPA1 [44,55,56]; rat CPA1 [57]; rat CPA2 (1J . 
rat MC-CPA [13]; mouse MC-CPA [12]; human MC-CPA [9] (this stu ~ 
Fig 3); rat ePB [57]; bovine CPB [45]; crayfish ePB [58], and S. grisellS C 
[59]. 
surface of the molecule (not shown), and therefore is potentiallY 
available for glycosylation [33]. The other site is not located 011 the 
surface of bovine CPA, and may not be glycosylated . 
Evolutionary Tree Analysis The most parsimonious evo1u: 
tionary tree (i.e., the one that requires the fewest amino acid rep~ace, 
ments and gene duplications to explain the modern sequence d1ve\ 
sity and known distribution) is shown in Fig Sa. This tree re9Ulreo 
1054 replacements. It places the divergence of the lineage lead!l1g t., 
crayfish CPB and lineage leading to the mammalian carboxypeptl, 
dases prior to the gene duplications that gave rise to the four !11a~t 
malian genes, CPA 1, CPA2, CPB, and MC-CPA. The next shortte 
trees (Fig 5b,c) each require 1062 amino acid replacements. 1" ,t 
shortest tree was not statistically significantly better than these ne~e 
two shortest trees. These trees place crayfish CPB either on tl e 
lineage leading to MC-CPA and CPB (Fig 5bjtree 2), or 011 ~;g 
lineage leading to the pancreatic CPAI and CPA2 enzymeS (I a[ 
5cjtree 3), Importantly for this study, all three trees docum~l1t~~J3 
MC-CPA arose from a gene duplication along the pancreatiC 
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a. Tree 1 
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Figure 5 G I tio . enea ogy of the carboxypeptidase gene family. a) The evolu-
rntaYbtree depicted here is the most parsimonious evolutionary tree deter-
rn ne y ammo aCid parsimony analysis (requiring 1054 amino acid replace-
(e;hs), b) and c) show the next two shortest trees for these nine sequences 
the\ reqUiring 1062 amino acid replacements). These trees are rooted using 
Cati actenal carboxypeptidase as an outgroup. Triallgles indicate gene dupli-
ber °f~ an~ the other divergences represent speciations; the minimum num-
of th upltcatlons that is required to explain the modern species distribution 
esc proteins is shown. 
linea h MC-~ rat er than along the pancreatic CPA lineage. When mouse 
sitnil PA [12] was used (rather than rat MC-CPA) to build trees, 
ar results were found. 
DISCUSSION 
Mast c 1I d hav b e proteases are useful markers for human mast cells, an 
tase
e 
een used to phenotype them. MCTC mast cells contain tryp-
rea' chymase [34], carboxypeptidase [35], and a proteinase cross-
o cellst~~ With antibodies against cathepsin G [7], whereas MCT mast 
cel! ntam only tryptase [34]. The content of MC-CPA in mast 
lun s obtamed from skin appears to be ten- to fortyfold higher than 
of ~~ast cells [36], presumably in part because of a higher percent 
o Tc mast cells in skin compared to lung (> 99% versus 7%). 
focu ur analysis of the amino acid sequence of human MC-CPA 
in p.ssed on those residues in the SI' subsite (marked by an asterisk enc~g 4} that may be important in determining the substrate prefer-cryst:l~ the carboxypeptidases with A-like activity. Because the 
ditn . tructure of MC-CPA has not been reported, only the three-rece~nslonal structure of bovine pancreatic CPA [15,29], and the 
B (p t ~port of the crystal structure of porcine procarboxypeptidase 
cel! ro PE) [37], may be used to model the SI' subsite in the mast 
sitnilcnzyme. The main chain conformation of this site is quite 
COtn ar m bovine CPA and porcine proCPB, and the amino acids 
pnsmgth' . II d ' I db' atic c b IS SIte are we conserve m t 1e rat an ovme pancre-
graphar Oxypeptidases (Fig 4). Therefore, pending future crystallo-
subs it Ie S?uctural data ofMC-CPA, it is reasonable to model the S1' 
detailedo MC-CPA on bovine CPA, for which we have the most 
residue itruc~ure, and to examine the replacements among the nine 
data w
e
.
s h ocaltzed to this subsite [11], in order to correlate sequence 
l'w It substrate preferences. 
and r 0 pancreatic carboxypeptidases with A-like activity, rat CPA1 
at CPA2, have been studied in order to correlate their se-
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quences and substrate specificity, using the substrate specificity of 
bovine pancreatic CPA as a reference [11]. It was proposed that the 
substrate preferences of these enzymes may be correlated with the 
size of the Sl' active site, because the substitution of a smaller resi-
due, Ala, for Thr268 in rat CPA 2 (Fig 4) correlated with a change 
in specificity toward higher-molecular-weight hydrophobics such 
as tryptophan, and the substitution of two bulkier residues, Ser for 
Gly 253, and Thr for Ser 254, in rat CPAI correlated with prefer-
ences skewed away from larger substrates. We were interested to see 
if this hypothesis predicted the behavior of human MC-CPA, in 
which Ile 247, Ser 252, Leu 254, and Ala 267 of MC-CPA (Fig 3) 
replace Ala 250, Gly 253, Ile 255, and Thr 268, respectively, of 
bovine CPA (marked by asterisks in Fig 4) . 
The Sl' subsite replacements of two bulkier, one isomeric, as well 
as one smaller residue in MC-CPA, represent a more complicated 
model of the S I' subsite than described for rat CPA 1 and CP A2, 
which have only bulkier or smaller amino acid substitutions, respec-
tively. Relative to bovine CPA, these S1' subsite replacements in 
MC-CPA result in a greater net positive change in non-hydrogen 
atoms and in volume in A3 [38] than the replacements in rat CPA1. 
Such changes might be expected to be associated with greater alter-
ations in specificity, similar to that exhibited by rat CPA1, than are 
actually observed between MC-CPA and bovine CPA (Table I). 
Like rat CPAl [11], MC-CPA did not hydrolyze carboxyl-terminal 
Trp, but unlike rat CPA1, MC-CPA hydrolyzed carboxy-terminal 
Tyr with similar overall catalytic efficiency compared to Phe (kc.J 
Km in Table I), and did not hydrolyze carboxyl-terminal Ala. There-
fore, it is apparent that the presumed overall size of the S l' pocket as 
predicted by amino acid replacements, may not be the sole determi-
nant of the C-terminal amino acid substrate preferences of these 
enzymes. It is reasonable to speculate that backbone differences 
between MC-CPA and bovine CPA will be larger than those be-
tween rat CPA 1 and bovine CPA, in order to compensate for these 
replacements, and still exhibit similar substrate preferences. This 
would also be consistent with the genealogy of MC-CP A, as larger 
backbone differences are expected between products of ar,cient gene 
duplications (i.e., MC-CPA and bovine pancreatic CPA) than be-
tween products of orthologous genes (i.e., rat CPAl and bovine 
pancreatic CPA). It is also likely that the position of the amino acid 
replacements in the S l' active site may also be critical, because this 
determines the shape of the pocket. For instance, in rat CPA1 the 
substitution ofThr for Ser 254 is in t~e base of the pocket, near the 
hydroxyl group of glycyltyrosine, and the position of this group 
may account for the fivefold lower hydrolytic activity of rat CPAI 
toward Cbz-Gly-Tyr, compared to Cbz-Gly-Phe [11]. Such a re-
placement does not occur in MC-CPA. 
Our data demonstrate that MC-CPA is probably glycosylated in 
vivo. Although the shift in apparent Mr on SDS-PAGE ofN-glyco-
sidase F treated MC-CPA (Fig 2a) was relatively small (-3500), it 
was almost identical in magnitude to that reported for similarly 
treated human and dog mast cell tryptases and chymases [16,17,39] . 
It is interesting to note that rat [13] and mouse MC-CPA [12] lack 
the consensus site most likely to be glycosylated [33], replacing Asp 
for Asn 147 (Fig 4). Although some rodent mast cell neutral pro-
teases are not glycosylated [40,41]' purified rat and mouse MC-CPA 
have not yet been so characterized. Pancreatic proteases are not 
glycosylated [30,42,43]. Further, bovine CPA and CPB lack both of 
the N-linked glycosylation sites identified in MC-CPA: Thr 129 
destroys one site, and Asp 148 replaces Asn in the second [44,45], as 
shown in Fig 4. The function of glycosylation of mast cell proteases 
is unknown, although it has been postu lated that glycosylation may 
protect dog mast cell chymase from autodegradation, and may playa 
role in intercellular processing and packaging in the mast cell secre-
tory granule [39]. In this light, it is interesting that purified rat 
MC-CPA appears to be less stable than its human homolog [13,46]. 
Pancreatic and mass cell carboxypeptidases are members of the 
same gene family and arose through gene-duplication events 
[2,9,11-13]. Of these enzymes, MC-CPA exhibit a unique rela-
tionship between amino acid sequence and substrate specificity: 
they are more similar in overall sequences to the pancreatic CPB 
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than to the CPA [2,9,12,13)' yet they have CPA-like substrate speci-
fiCIty [1,2,46,47). Our study of MC-CPA has provided further in-
sight into the evolutionary divergence within this family. The 
gene-duplication event that gave rise to MC-CPA appears to have 
occurred along the vertebrate CPB lineage subsequent to its diver-
gence from the lineage leading to CPAI and CPA2 (Fig 5). This 
may help explain why the residue considered critical for conferring 
CPA-ltke substrate specificity to the pancreatic CPA (i.e., lie 255 in 
bovine CPA) [15,45,48) is Leu in human, mouse, and rat MC-CPA. 
CPA-like specificity appears to have been invented independently 
by MC-CPA, a gene duplicate along the CPB lineage. Because this 
duplication event apparently occurred before later speciation diver-
gence of CPB, it is not surprising that MC-CPA is found in other 
mammals. Although mast cells are found in lower vertebrates, such 
as carp (Cyprinus carpio), leopard frogs (Rana pidiens), and turtles 
(Chrysel'llyn picta), these species have not been investigated for the 
presence of MC-CPA [49); thus we do not know how early in 
vertebrate evolution MC-CPA arose. 
In the mouse and rat there is substantial evidence for the existence 
of multiple chymase genes that are differentially expressed in differ-
ent mast cell types [8,40,41,50-53). Our previous work demon-
strated multiple human mast cell tryptase cDNA [10,54), some of 
which may be differentially expressed by mast cells in different 
human tissues [15). In contrast, the current evidence is consistent 
with the view that there is a single gene for Me-CPA in human or 
mouse [9,12). 
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ERRATA 
Please note the following corrections to "Acute or chronic topical retinoic acid treatment of 
human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, 
filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14," Volume 98, March 1992, 
pp 343-350. 
Figure 1 legend: The bar should be 1.1 inches in length, representing 0.1 mm. 
Figure 6 legend: The sentence "Right: RA-treated epidermis (X50)" shou ld be deleted. 
Figure 7 legend: "Top row" should read "Left" and "Bottom row" should read "Right" . The 
words "left columlt," "middle column," and "right column" should all be deleted. 
